Sun Pharma is one of the largest pharmaceutical companies in India, with a strong presence in both the domestic and international markets. In recent years, Sun Pharma’s share price has been a topic of interest for investors and analysts alike, as the company has been consistently performing well.
Sun Pharma’s recent announcement of the acquisition of American company Concert for $576 million has also generated a lot of buzz and speculation about the future of the company. In this article, we will take a closer look at Sun Pharma’s share price target for the years 2023 to 2030 and whether it is a good auto stock to buy.
We will also explore the impact of the acquisition on Sun Pharma’s financials and growth prospects.
Latest news about Sun Pharma
➤ Sun Pharma was reprimanded by the USFDA for shortcomings at its Halol plant.
➤ Sun Pharma announces the acquisition of American company Concert for $576 million.
How to buy Sun Pharma shares?
You can buy Sun Pharma shares from the following trading platforms:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
Share Price Prediction of Sun Pharma: 2023 to 2030
Sun Pharma Share Price Target 2023
| When | Maximum Price | Minimum Price |
| February 2023 | ₹1,028.15 | ₹790.88 |
| March 2023 | ₹981.11 | ₹893.16 |
| April 2023 | ₹948.22 | ₹752.48 |
| May 2023 | ₹906.85 | ₹743.73 |
| June 2023 | ₹848.22 | ₹652.48 |
| July 2023 | ₹1,017.87 | ₹782.98 |
| August 2023 | ₹1,119.66 | ₹861.27 |
| September 2023 | ₹1,175.64 | ₹904.34 |
| October 2023 | ₹1,119.66 | ₹861.27 |
| November 2023 | ₹1,231.62 | ₹947.40 |
| December 2023 | ₹1,379.42 | ₹1,061.09 |
According to the table, Sun Pharma’s share price is expected to show a bullish trend in 2023, with the maximum price expected to reach ₹1,379.42 in December 2023 and the minimum price expected to be ₹743.73 in May 2023. The growth percentage is expected to be significant, with the price increasing by more than 85% from its minimum to its maximum.
Throughout 2023, the uptrend is expected to continue, with the maximum price being higher in the latter half of the year compared to the first half. The price is expected to be relatively stable in the months of February, June, and October, with minimum and maximum prices being relatively close to each other.
In conclusion, the Sun Pharma share price is expected to show a positive trend in 2023, with significant growth expected throughout the year.
Sun Pharma Share Price Target 2024
| When | Maximum Price | Minimum Price |
| January 2024 | ₹1,452.02 | ₹1,116.94 |
| February 2024 | ₹1,631.48 | ₹1,359.57 |
| March 2024 | ₹1,717.35 | ₹1,396.22 |
| April 2024 | ₹1,561.22 | ₹1,200.94 |
| May 2024 | ₹1,301.02 | ₹1,000.78 |
| June 2024 | ₹1,561.22 | ₹1,200.94 |
| July 2024 | ₹1,327.04 | ₹1,028.71 |
| August 2024 | ₹1,459.74 | ₹1,158.53 |
| September 2024 | ₹1,532.73 | ₹1,179.02 |
| October 2024 | ₹1,803.21 | ₹1,387.09 |
| November 2024 | ₹1,893.37 | ₹1,456.44 |
| December 2024 | ₹1,931.24 | ₹1,485.57 |
Sun Pharma’s share price looks bullish in 2024, with the maximum price reaching ₹1,931.24 in December 2024 and the minimum price expected to be ₹1,000.78 in May 2024. The growth percentage is expected to be substantial, with the price increasing by nearly 93% from its minimum to its maximum.
Throughout 2024, the upward trend is expected to persist, with the maximum price being higher in the latter half of the year compared to the first half. The price is expected to show some volatility in the months of April and June, with minimum and maximum prices being relatively far from each other.
Sun Pharma Share Price Target 2025
| When | Maximum Price | Minimum Price |
| January 2025 | ₹1,969.87 | ₹1,515.28 |
| February 2025 | ₹2,073.54 | ₹1,595.03 |
| March 2025 | ₹2,177.22 | ₹1,674.79 |
| April 2025 | ₹1,943.95 | ₹1,495.34 |
| May 2025 | ₹1,767.22 | ₹1,359.40 |
| June 2025 | ₹1,943.95 | ₹1,495.34 |
| July 2025 | ₹1,851.38 | ₹1,424.14 |
| August 2025 | ₹1,928.52 | ₹1,483.48 |
| September 2025 | ₹2,024.94 | ₹1,557.65 |
| October 2025 | ₹2,146.44 | ₹1,651.11 |
| November 2025 | ₹2,296.69 | ₹1,766.69 |
| December 2025 | ₹2,342.63 | ₹1,802.02 |
Sun Pharma is projected to have a fluctuating share price target in 2025, with the maximum share price target reaching ₹2,342.63 in December 2025 and the minimum share price target being ₹1,515.28 in January 2025.
Throughout the year, the company’s share price is expected to show growth, with several months seeing a significant increase in the maximum price target. Despite the fluctuations in the share price target, the overall trend for Sun Pharma in 2025 is upward, which may make it a good opportunity for investment.
Sun Pharma Share Price Prediction 2026-2030
| Year | Maximum Price | Minimum Price |
| 2026 | ₹1,639.84 | ₹1,147.89 |
| 2027 | ₹1,393.86 | ₹975.70 |
| 2028 | ₹2,508.95 | ₹1,756.27 |
| 2029 | ₹5,153.78 | ₹3,607.64 |
| 2030 | ₹5,739.43 | ₹4,017.60 |
Sun Pharma is expected to have a varying share price in the coming years from 2026 to 2030. The share price is projected to reach a maximum of ₹5,739.43 in 2030 and a minimum of ₹975.70 in 2027. In 2026, the share price is expected to range from ₹1,639.84 to ₹1,147.89, while in 2028, it is expected to range from ₹2,508.95 to ₹1,756.27.
The company has seen significant growth in recent years, with the share price increasing from ₹1,379.42 in 2023 to ₹2,342.63 in 2025. These projections are based on current market trends and conditions, and actual results may vary.
Financial Condition of Sun Pharma: Last 5 years
| Narration | Mar-18 | Mar-19 | Mar-20 | Mar-21 | Mar-22 |
| Sales | 26,489.46 | 29,065.91 | 32,837.50 | 33,498.14 | 38,654.49 |
| Expenses | 20,858.04 | 22,688.93 | 25,854.66 | 25,028.18 | 28,396.92 |
| Operating Profit | 5,631.42 | 6,376.98 | 6,982.84 | 8,469.96 | 10,257.57 |
| Other Income | -135.03 | -258.28 | 382.26 | -3,449.21 | -3,505.16 |
| Depreciation | 1,499.84 | 1,753.25 | 2,052.78 | 2,079.95 | 2,143.74 |
| Interest | 517.57 | 555.25 | 302.73 | 141.43 | 127.35 |
| Profit before tax | 3,478.98 | 3,810.20 | 5,009.59 | 2,799.37 | 4,481.32 |
| Tax | 911.04 | 600.88 | 822.80 | 514.69 | 1,075.50 |
| Net profit | 2,095.70 | 2,665.42 | 3,764.93 | 2,903.82 | 3,272.73 |
| EPS | 8.73 | 11.11 | 15.69 | 12.10 | 13.64 |
| Price to earning | 56.68 | 43.10 | 22.45 | 49.39 | 67.06 |
| Price | 495.10 | 478.85 | 352.30 | 597.80 | 914.75 |
| RATIOS: | |||||
| Dividend Payout | 22.90% | 24.75% | 25.49% | 61.97% | 73.31% |
| OPM | 21.26% | 21.94% | 21.26% | 25.28% | 26.54% |
Sun Pharma has seen significant growth over the past five years, with a steady increase in sales, operating profit, and net profit. The company’s sales rose from ₹26,489.46 crore in March 2018 to ₹38,654.49 crore in March 2022, representing a 46% growth in revenue. The operating profit margin (OPM) has consistently remained around 21-27%, with a maximum of 26.54% in March 2022. The net profit has also increased by 56% from ₹2,095.70 crore in March 2018 to ₹3,272.73 crore in March 2022.
The earnings per share (EPS) have also seen a steady increase, with a maximum of ₹13.64 in March 2022. The price to earnings (P/E) ratio has also been fluctuating, with a maximum of 67.06 in March 2022. The dividend payout percentage has increased from 22.90% in March 2018 to 73.31% in March 2022. The company’s consistent growth in sales, operating profit, and net profit reflects its overall financial stability and growth potential.
Sun Pharma share price target by Experts
Sun Pharma share price target by JM Financial
JM Financial has issued a buy recommendation for Sun Pharmaceutical Industries with a predicted value of Rs 1180.
Sun Pharma share price target by Jefferies
Jefferies has maintained a buy recommendation for Sun Pharmaceutical Industries with a predicted value of Rs 1200.
FAQS
Will the share price of Sun Pharma increase in 2023?
It is anticipated that Sun Pharma per share price will increase to ₹1,379.42 by the end of 2023.The bullish trend and the uptrend indicate that 2023 could be a good year for Sun Pharma shareholders.
What is the share price target of Sun Pharma for 2025?
The share price target of Sun Pharma for 2025 might be around ₹2,342.63. This growth is a positive sign for Sun Pharma and its investors, indicating the company is poised for continued success in the future.
What is the share price target of Sun Pharma for 2030?
The per share price of Sun Pharma might reach around Rs. 5,739.43 by the end of 2030.
Also read:
- What to Expect During a Home Appraisal?
- Adani Group stocks under extra surveillance by NSE as stocks face massive sell-off.
- 5 Tips to Landing a Job During a Recession.
Conclusion
Based on the financial results reported in September 2022, it appears that Sun Pharma, an Indian pharmaceutical company, is experiencing strong growth. The company’s revenue has increased by 13.78% year over year, and its operating expenses have also increased by 14.77%. Despite the increase in expenses, Sun Pharma has still managed to achieve a net income of 22.62 billion Indian rupees, representing a growth of 10.51% compared to the previous year.
According to the financial results, it suggest that Sun Pharma is a financially strong and growing company and could be a good pharma stock to buy in 2023. However, please do not invest all your money at one go. I suggest investing not more than 0.5% of your total portfolio in this pharma stock.
